首页|血清CD62P、sTREM-1水平预测老年冠心病患者PCI术后主要心血管不良事件发生的价值

血清CD62P、sTREM-1水平预测老年冠心病患者PCI术后主要心血管不良事件发生的价值

扫码查看
目的 探究血清P选择素(CD62P)、可溶性髓样细胞表达触发因子受体1(sTREM-1)水平对老年冠心病患者经皮冠状动脉介入治疗(PCI)术后主要心血管不良事件发生的预测价值.方法 选取2019年1月至2022年1月在本院就诊的160例老年冠心病患者为研究对象,采用流式细胞仪检测血清中CD62P水平;人sTREM-1 ELISA试剂盒检测血清中sTREM-1水平;根据出院后12个月的随访结果将老年冠心病患者分为未发生心血管不良事件组(108例)和发生心血管不良事件组(52例);多因素Logistic回归分析老年冠心病患者PCI术后主要心血管不良事件发生的危险因素;采用受试者工作特征(ROC)曲线评价血清CD62P、sTREM-1水平对老年冠心病患者PCI术后主要心血管不良事件发生的预测价值.结果 与未发生心血管不良事件组比较,发生心血管不良事件组患者血清中CD62P、sTREM-1水平升高(P<0.05);老年冠心病患者糖尿病史、心绞痛史、冠脉病变个数、置入支架数目与发生心血管不良事件相关(P<0.05);多因素Logistic回归分析结果显示,CD62P高表达、sTREM-1高表达、有糖尿病史、有心绞痛史、冠脉病变个数>1、置入支架数目>2是老年冠心病患者PCI术后发生主要心血管不良事件的危险因素(P<0.05);CD62P、sTREM-1联合预测老年冠心病患者PCI术后发生主要心血管不良事件的AUC显著大于CD62P单独预测的AUC(Z=3.116,P=0.002).结论 血清CD62P、sTREM-1水平对老年冠心病患者PCI术后主要心血管不良事件发生可能具有一定的预测价值.
The Value of Serum CD62P and sTREM-1 Levels in Predicting the Occurrence of Major Cardiovascular Adverse Events in Elderly Patients with Coronary Heart Disease After PCI
Objective To explore the predictive value of serum P-selectin (CD62P)and soluble myeloid cell expression triggering factor receptor 1 (sTREM-1 )levels for major cardiovascular adverse events in elderly patients with coronary heart disease after percutaneous coronary intervention (PCI).Methods A total of 160 elderly patients diagnosed with coronary heart disease who were treated in our hospital from January,2019 to January,2022 were selected as the study subjects.The level of CD62P in serum sample was detected by flow cytometry;Human sTREM-1 ELISA kit was applied to detect the level of sTREM-1 in serum samples;According to the follow-up results during 12 months after discharge,the elderly patients with coronary heart disease were divided into two groups:the non-cardiovascular adverse events group (108 cases)and the cardiovascular adverse events group (52 cases);Multivariate logistic regression was applied to analyze the risk factors of major cardiovascular adverse events in elderly patients with coronary heart disease after PCI;ROC curve was drawn to evaluate the predictive value of serum levels of CD62P and sTREM-1 for the occurrence of major adverse cardiovascular events in elderly patients with coronary heart disease after PCI. Results Compared with the non-cardiovascular adverse events group,serum levels of CD62P and sTREM-1 in the cardiovascular adverse events group were higher (P<0.05);The medical history of diabetes,angina pectoris,the number of coronary artery lesions,and the number of stents were related to the occurrence of cardiovascular adverse events (P<0.05 );Multivariate logistic regression analysis showed that high expression of CD62P,high expression of sTREM-1,medical history of diabetes,angina pectoris,number of coronary artery lesions >1,and number of stents >2 were risk factors (P<0.05);AUC of CD62P and sTREM-1 in predicting major adverse cardiovascular events was significantly higher than that of CD62P alone (Z=3.116,P=0.002).Conclusion Levels of serum CD62P and sTREM-1 have certain predictive value for the occurrence of major adverse cardiovascular events in elderly patients with coronary heart disease after PCI.

Coronary heart diseasePercutaneous coronary interventionP-selectinSoluble triggering receptor expresses on myeloid cells-1Major cardiovascular adverse events

印章、付永波、朱冬梅、凡洋、徐进林

展开 >

长江大学附属仙桃市第一人民医院心血管内科,湖北 仙桃 433000

冠心病 经皮冠状动脉介入治疗 P选择素 可溶性髓样细胞表达触发因子受体1 主要心血管不良事件

仙桃市卫生健康委项目

WJ2021F099

2024

标记免疫分析与临床
中国同辐股份有限公司

标记免疫分析与临床

CSTPCD
影响因子:0.978
ISSN:1006-1703
年,卷(期):2024.31(3)
  • 19